Q1 2025 Earnings Call Transcript May 16, 2025 Operator: Good day and welcome to the Abeona Therapeutics First Quarter 2025 ...

SAN DIEGO (AP) — J.P. Crawford homered on Stephen Kolek's first pitch and Rowdy Tellez and Cal Raleigh each added a two-run ...

The Seattle Mariners and San Diego Padres will play for the ‘Vedder Cup,’ beginning with a three-game series in Seattle ...

Epidermolysis Bullosa Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Epidermolysis Bullosa Global Market Report 2025 - Market Size ...

ZEVASKYN TM (prademagene zamikeracel) is an autologous cell sheet-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis ...

Epidermolysis Bullosa, also colloquially known as butterfly skin disease, a rare genetic condition that makes your skin very ...

The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

The biotech has quickly turned a cell therapy approval into one of the more lucrative recent sales for a priority review ...

TORONTO — Riley Greene homered and drove in three runs, Javier Báez and Zach McKinstry also connected and the Detroit Tigers ...

for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic skin disorder. RDEB is characterized by extensive blistering and ...